Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study.
Vikram Muralidhar HaridasRahul KattaAjit NalawadeSandeep KharkarVyacheslav ZhdanOlena GarmishLuis López-LázaroSonica Sachdeva BatraSuresh KankanwadiPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
ClinicalTrials.gov identifier: NCT02296775.